Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Merck Frosst synthesizes potent, selective and orally active PDE4 inhibitors

Dec. 18, 2000

Two series of inhibitors of alpha4beta1-mediated cell adhesion claimed by Aventis

Dec. 18, 2000

Inhibitors of Lp-PLA2 and their use in atherosclerosis described by SB in recent patent

Dec. 18, 2000

Large group of MEK-inhibitory quinolines discovered at AstraZeneca

Dec. 18, 2000

More PARP inhibitors identified at BASF

Dec. 15, 2000

Recent patent covers selective COX-2 inhibitors synthesized at Merck Frosst

Dec. 15, 2000

Potential new contraceptive agents patented by Schering

Dec. 15, 2000

Novel Aventis compounds for cardiovascular disorders interact with angiotensin receptors

Dec. 15, 2000

New progesterone receptor modulators continue to emerge from AHP/Ligand alliance

Dec. 15, 2000

Roche presents new antitumor agents acting on cyclin-dependent kinases

Dec. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026